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Abstract
Background: Polycystic Ovary Syndrome (PCOS) is an endocrine disorder in women of reproductive age with an
estimated prevalence of 5–20% of premenopausal women. The clinical symptoms common to PCOS include
menstrual dysfunction, hyperandrogenemia, hirsutism, polycystic ovaries, insulin resistance, and hyperinsulinemia. Women
with PCOS are at an increased risk of infertility, obesity and type 2 diabetes mellitus. Insulin resistance and
hyperinsulinemia are believed to be key contributing factors to the pathogenesis of PCOS; excessive amounts
of insulin are directly associated with the increased ovarian production of androgens and metabolic features
of PCOS. Pulse-based diets (e.g., beans, chickpeas) are associated with improved glycemic control and have
insulin lowering effects. The purpose of this study is to determine whether a pulse-based diet is more effective than
the diet recommended by the National Cholesterol Education Program. The primary outcomes of this study are disease
measures related to PCOS, with secondary outcomes including measures related to metabolic syndrome.
Methods: Women with symptoms of PCOS will be recruited for the study and a diagnosis of PCOS will be determined
by an obstetrician-gynecologist. Women with PCOS will be randomly assigned to receive either a pulse-based diet or the
National Cholesterol Education Program therapeutic lifestyle changes (TLC) diet for 16 weeks while participating in an
aerobic exercise program. One hundred participants will be required (drop-out rate of 32%) for recruitment to provide
80% power for detecting a significant difference in fasting glucose (p < 0.05). Measures related to infertility, metabolic
syndrome, quality of life, dietary intake and physical activity will be assessed pre- and post-intervention with follow up
assessment at 6- and 12-months post-intervention.
Discussion: Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age
and there is currently no recommended diet for this population of women. The multidisciplinary nature of
this study, including determination of measures related to metabolic syndrome, infertility and physical activity
provide a comprehensive assessment of any benefits associated with a pulse-based diet in women with PCOS.
The results of this study will help in providing evidence-based recommendations for the optimum diet to reduce
symptoms associated with PCOS.
Trial registration: NCT01288638. Trial registered January 13, 2011.
Keywords: Pulses, Polycystic ovary syndrome, Randomized controlled trial, Metabolic syndrome
* Correspondence: gordon.zello@usask.ca
1College of Pharmacy and Nutrition, University of Saskatchewan, 107 Wiggins
Road, Saskatoon, SK S7N 5E5, Canada
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
McBreairty et al. BMC Nutrition  (2017) 3:23 
DOI 10.1186/s40795-017-0142-6
Background
Polycystic Ovary Syndrome (PCOS) is an endocrine dis-
order in women of reproductive age with an estimated
prevalence of 5%–20% of premenopausal women [1, 2].
The clinical symptoms common to PCOS include men-
strual and ovulatory dysfunction, hyperandrogenemia,
hirsutism, polycystic ovaries, insulin resistance, and hyper-
insulinemia [3]. A diagnosis of PCOS is associated with an
increased risk of infertility, dysfunctional bleeding, en-
dometrial carcinoma, obesity, type 2 diabetes mellitus,
dyslipidemia, hypertension, and possibly cardiovascular
disease [3–6]. The pathogenesis of PCOS is not fully
understood; however, insulin resistance and associated
hyperinsulinemia that affect 50–70% of women with
PCOS are believed to be key contributing factors [7, 8].
Insulin resistance and the subsequent production of ex-
cessive amounts of insulin are directly associated with the
increased ovarian production of androgens and the fea-
tures of PCOS [9]. Lifestyle modifications, including diet
and exercise, are currently the first-line treatment recom-
mended for women with PCOS [10]; however, there are
currently no specific diet recommendations for women
with PCOS.
Pulses (e.g., lentils, chick peas, split peas, beans) are
high in fiber, have a low-glycemic index, are low in fat,
and contain high quality protein. Pulse-based diets are
also effective for lowering fasting blood glucose, insulin
and blood pressure [11, 12]. These nutritional qualities
are important for reducing the risk of metabolic-related
and cardiovascular diseases such as diabetes. Pulse con-
sumption has been shown to result in positive effects in
individuals at risk for metabolic syndrome [13]. Al-
though clinical trials have demonstrated positive health
effects of dietary pulse consumption, some studies have
limitations such as insufficient follow up time [11] as
well as lack of consistency in dose and disease pheno-
type [12]. Furthermore, the need for more ‘real world’
trials measuring compliance has been highlighted [11].
In women with PCOS, insulin resistance has been
shown to be independent of obesity [14]. Hyperinsuline-
mia and adiposity exacerbate metabolic and reproductive
abnormalities in women with PCOS [15–19]; therefore,
our objective is to test the hypothesis that a pulse-based
diet can improve symptoms related to metabolic syn-
drome, infertility and menstrual cycle regularity in
women with PCOS. The purpose of this manuscript is to
detail the study design and methodology used in a ran-
domized clinical trial involving a diet and exercise inter-
vention in women with PCOS.
The primary outcome measures of this study are dis-
ease measures related to PCOS including sex hormones
and numbers of ovarian follicles. Secondary outcomes of
this study include measures related to metabolic syn-
drome, quality of life, physical activity and diet.
Methods
Design overview
The present study is a single-blind, parallel, stratified-
randomized clinical trial. The work is funded by Saskatch-
ewan Pulse Growers and Agriculture Agri-Food Canada.
The study design is detailed in Fig. 1. The aim of the study
is to determine the effect of a pulse-based diet compared
to a healthy control diet on disease measures related to
PCOS as well as metabolic syndrome risk factors in
women with PCOS while they are enrolled in an exercise
program. After the study coordinator obtains informed
signed consent, study participants will be assessed to deter-
mine whether they have PCOS. Women diagnosed with
PCOS will undergo baseline testing followed by a 2-week
lead-in period on the healthy control diet (therapeutic life-
style changes (TLC) recommended by the National
Cholesterol Education Program). Following the lead-in,
participants will repeat baseline blood measures followed
by randomization to either the pulse-based diet or the TLC
diet for 16-weeks while participating in an aerobic exercise
program. Blood measures will be assessed after 9-weeks
and at the end of the 16-week intervention, participants
will undergo end of intervention testing; follow-up mea-
sures will also be assessed at 6-months and 12-months.
The primary outcome of this study is to determine the
effectiveness of a pulse-based diet compared to a healthy
control diet (TLC diet) for improving PCOS disease mea-
sures including sex hormones, menstrual cycle length and,
numbers of ovarian follicles. Secondary outcomes include
1) Measures of metabolic syndrome including liver adi-
posity; 2) Body composition; 3) Quality of life; 4) Physical
Activity; and, 5) Diet.
Setting
The study will be conducted in Saskatoon, SK Canada and
is a joint project between investigators in the Colleges of
Pharmacy and Nutrition, Kinesiology, and Medicine at the
University of Saskatchewan. All medical diagnostic ap-
pointments will take place at the Royal University Hospital
in Saskatoon. Other assessments will take place at a
College of Kinesiology research facility on the University of
Saskatchewan campus. Ethics approval and approval for all
protocol amendments will be obtained via the University
of Saskatchewan Research Ethics Board. All study proce-
dures will be conducted in full compliance with the Tri-
Council Policy Statement on the Ethical Conduct for Re-
search Involving Humans, the Declaration of Helsinki on
ethical principles for medical research involving humans,
and in compliance with the guidelines of the International
Conference on Harmonization on Good Clinical Practice.
Recruitment
Women will be recruited via regular posts on the Uni-
versity of Saskatchewan student and faculty online
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bulletin board. Women will also be recruited by posters
located throughout the University of Saskatchewan,
physician offices, health care establishments, and adver-
tisements in local newspapers. The study coordinator
will also meet with primary care physicians at clinics in
Saskatoon to provide information about the study as
well as to distribute consent forms to give to potential
participants. Recruitment will also take place via the
clinical practice of one of the researchers involved in the
study (DRC).
Population
Eligibility criteria require that volunteers be 18–35-year
old females with symptoms of missed or irregular men-
strual periods. Participation in the intervention is based
on a clinical diagnosis of PCOS. Each participant will be
assessed clinically to confirm the diagnosis of PCOS
which will be made by an obstetrician-gynecologist spe-
cializing in PCOS using criteria specified in the PCOS
report of the Androgen Excess-PCOS Society Task Force
[3]. Diagnosis of PCOS requires presence of two of the
three diagnostic criteria as defined by the Rotterdam
consensus: A self-reported history of cycles >35 days in
length, hyperandrogenism as defined by a Ferriman and
Gallwey score of >6 or hyperandrogenemia [3], as well
as polycystic ovaries (PCO), defined as >25 follicles visu-
alized by transvaginal ultrasonography to reflect the
newest guidelines for PCO recommended by the
Androgen Excess and Polycystic Ovary Syndrome Society
[20, 21]. Women with the following conditions will be ex-
cluded: Taking anti-seizure or anti-psychotic medications
known to induce development of insulin resistance and
polycystic ovaries; untreated hyperprolactinemia or thy-
roid disease; or, excessive adrenal androgen production
confirmed by a diagnosis of congenital adrenal hyperpla-
sia, Cushing’s syndrome, or an adrenal tumor. Women
using hormonal birth control methods during the prior
3 months or who have a medical condition limiting exer-
cise or consumption of a pulse-based diet (allergies or in-
tolerances) will be excluded. Women will also be excluded
from the study if they have an uncontrolled medical con-
dition that interfered with ovarian or systemic hormone
production, are pregnant or breastfeeding, or reside out-
side of the local geographic area.
Sample size
A pilot study (unpublished) was carried out on preliminary
data from 41 women with PCOS randomized to the pulse-
based or TLC diet. Thirteen of the 41 women dropped out
of the study giving a dropout rate of 32%. Changes in fast-
ing glucose following the intervention (n = 28) was used to
determine the required sample size for recruitment into
the study. Changes in the mean fasting glucose were -0.18
and 0.14 mmol/L for the pulse-diet group and TLC group,
respectively, with a population standard deviation of 0.46
and an effect size of -0.70. The pilot data provided 80%
Fig. 1 CONSORT flow diagram of study timeline for pulse-based diet intervention in women with polycystic ovary syndrome
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power for detecting a significant difference in fasting glu-
cose concentration between groups (p < 0.05) following
the intervention. It was determined 34 participants per
group would be required for the study. Due to the dropout
rate of 32%, the recruitment of 100 participants (i.e. 50 per
group) was determined necessary.
Randomization
During the 2-week lead-in period, participants will be
randomized to either the pulse based diet or control
TLC diet. Participants will be notified of diet allocation
via email (and are not blinded). Randomization will be
performed by an investigator who is not involved in
obtaining or entering participant data. Randomization
will be stratified based on the current use of the insulin
sensitizing drug Metformin, using a computer-generated
allocation schedule with a block size of 4.
Baseline measures
Prior to starting the 2-week lead-in phase and interven-
tion, all participants will undergo baseline assessments.
Assessments include a transvaginal ultrasound, fasting
clinical blood measures of reproductive hormones and
metabolic syndrome risk factors, glucose tolerance test
(GTT) including blood sample for measurement of non-
clinical metabolic syndrome risk factors, anthropometric
measures, dual-energy X-ray absorptiometry (DXA), phys-
ical activity assessment via accelerometer and leisure-time
activity questionnaire, 4-day food record, pulse survey
questionnaire, and quality of life questionnaire.
Study phases
The study will consist of 3 phases: 1) Lead-in phase; 2)
Intervention; and, 3) Maintenance.
Lead-in phase
All participants will follow a 2-week lead-in phase with
the purpose of controlling for diet variability in baseline
blood measures. The lead-in phase involves an initial
1.5-h meeting with a registered dietitian who will discuss
the participant’s baseline 4-day food record that will be
given during assessment of other baseline measures. The
dietitian will provide handouts on and explain the con-
trol TLC guidelines to each participant. The guidelines
were developed by the National Cholesterol Education
Program (NCEP) Expert Panel on Detection, Evaluation,
and Treatment of High Blood Cholesterol in Adults
[22]. Participants will also be provided with Canada’s
Food Guide which gives daily recommendations of 7-8
servings of fruit and vegetables, 6-7 servings of grains, 2
servings of milk or alternatives, and 2 serving of meat or
alternatives. The dietitian will explain healthy choices for
each food group based on the TLC guidelines which in-
clude choosing whole grains and fiber rich foods, lower-
fat milk and milk alternatives, and lean meats and meat
alternatives, as well as eating less fat and choosing
healthy fats more often, and limiting salt, sugar, and al-
cohol intake.
The lead-in approach has been used by others [23, 24]
to control for differences at baseline in measures that
might be influenced by previous diet (i.e., ensuring simi-
larity in baseline measures, such as blood parameters,
between the 2 groups). After completion of the 2-week
lead-in period, participants will repeat the assessment of
clinical blood measures of reproductive hormones and
metabolic syndrome risk factors.
Intervention
Following the 2-week lead-in phase, participants will be
randomized to either the pulse-based diet or TLC diet
and commence the 16-week diet and exercise interven-
tion. The 16-week time period is based on a review of
pulse-based diets for improving insulin and glucose
levels [11]. In addition, the length of intervention is re-
quired to observe changes in outcome measures related
to fertility. After 4-weeks of intervention, participants
will meet with the study coordinator to discuss any diffi-
culties with participating in the study and hand in the
first 4-weeks of study documents which include the daily
food and exercise log as well as a 1-day food record and
leisure-time exercise questionnaire. After 9 weeks of the
intervention, blood will be collected for clinical mea-
sures of reproductive hormones and metabolic syndrome
risk factors. At the end of the 16-week intervention,
baseline measures will be repeated.
Maintenance
During the final phase of the study, participants will be
followed up at 6-months and 12-months post interven-
tion to determine if participants are continuing to follow
the “standard of care” recommendations (i.e., TLC diet
and exercise) and for volunteers randomized to the
pulse-based diet, to determine if they continue to follow
a pulse-based diet. Six-month and 12-month follow-up
measures include a transvaginal ultrasound, GTT, clin-
ical blood measures of reproductive hormones and
metabolic syndrome risk factors, DXA, anthropometric
measures, pulse survey questionnaire, and quality of life
questionnaire. In addition, physical activity will be
assessed via accelerometer at the 6-month follow up.
Exercise
A gym orientation at the College of Kinesiology research
gym facility will be provided to familiarize the partici-
pants with the aerobic equipment used during the super-
vised gym activity. The exercise-training laboratory is
fully equipped with aerobic exercise machines and is re-
served exclusively for research participants. Aerobic
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activity will be prescribed as part of the recommended
“standard of care” and to reduce variability in this life-
style factor between participants. Standard of care of ex-
ercise training and the TLC guidelines reduces variability
among our participants. It is also a design which is ethic-
ally sound as it would not be ethical to include a control
group that received no care because women with PCOS
are a population that requires treatment.
Prior to the beginning of the intervention, the subjects’
current level of physical activity will be assessed via a
validated Physical Activity Questionnaire [25]. Exercise
training will involve aerobic training 5 days/week for
45 min/day with 3 required sessions in our physical ac-
tivity facility in the College of Kinesiology at the Univer-
sity of Saskatchewan. This allows research assistants to
monitor and support participants as well as address any
issues encountered. Exercise will involve walking or
training on elliptical machines, rowing machines or sta-
tionary bikes, depending on the individual participant’s
preferences. Participants will be encouraged to exercise
at an intensity of at least 60% of their age-predicted
maximal heart rate (i.e., 220 minus age). Instruction will
be provided by a research assistant on how to calculate
and obtain heart rate measures. This amount of aerobic
exercise is the minimal level of exercise shown to be
beneficial for improving blood lipids [26].
Diet
Women in the TLC group will be instructed to continue
following the TLC diet prescribed during the lead-in phase.
Women in the pulse group will be provided with two pulse
meals per day and instructed to follow the TLC guidelines
for breakfast and snacks. The pulse-based diet will include
a variety of meals prepared with dry peas, lentils, chick
peas and faba beans. Two standard meals will be supplied
per day to participants (i.e., lunch, dinner) containing ap-
proximately 150 g per day of pulses dry weight (250 g per
day wet weight). These quantities are based on amounts
proven beneficial for lowering blood glucose and lipid
levels [13, 27, 28]. The research team will be in contact
with participants about food preferences and allergies and
participants will have input into which meals are received
out of the variety of meals including frozen and fresh op-
tions. Meals will be picked up weekly by participants at the
exercise facility. Subjects will be counseled to replace foods
normally eaten for lunch and supper with the pulse-based
food so as not to increase daily caloric intakes.
Compliance
Compliance to both diet and exercise will be monitored
using a daily diet and exercise log book as well as a 1-
day food record after every 4-weeks of following the
intervention. All participants will be instructed to record
daily exercise activity and duration. Women randomized
to the pulse group will be required to log which pulse
meals are consumed as well as the percentage consumed
and both groups will be required to record whether the
TLC guidelines are followed each day for all non-
prescribed meals, which are all meals for TLC group.
Measurements
Pulse consumption questionnaire
The pulse consumption questionnaire is a modified ver-
sion of the validated DAILY (Diet Approaches to In-
crease Lentils in Youth) questionnaire and will be
administered at enrollment (prior to TLC guideline
counseling) to determine the beliefs and barriers to the
consumption of pulses in this population, as well as their
current intake of pulses in their diet [29]. The DAILY
questionnaire was developed by our research group and
has been used in diverse populations.
Quality of life questionnaire
The quality of life questionnaire, Quality-of-Life Ques-
tionnaire for Women with Polycystic Ovary Syndrome,
has been previously validated and used to examine the
psychological impact of having PCOS and the effect of
participation in an intervention [30, 31].
Accelerometer
Physical activity and time sedentary will be objectively
measured using the Actical™ (MiniMitter, Bend, Oregon)
accelerometer, a uniaxial accelerometer that detects ver-
tical acceleration. The Actical™ has been validated to
measure physical activity in adults [32]. Accelerometers
will be used at the beginning of the study to measure
the participants’ usual activity (i.e., before exercise pro-
gram). The Actical (28 x 27 x 10 mm/17 g) will be worn
by the participants on a belt worn around the waist with
the accelerometer situated at the hip, which will be dem-
onstrated by a research assistant. Participants will be
given the monitor on day 1 with data collection pro-
gramed to record for 7 consecutive days, starting at
12:00 am on day 2 and ending at 12:00 am on day 8.
Participants will be encouraged to wear the device on
day 1 prior to start of data collection. The participants
will be asked to wear the monitor at all times while
awake, with the exception of water based activities such
as bathing and swimming. The digitized values from the
accelerometer are summed over a user-specified interval
of 60 s, resulting in a count value per minute (cpm).
Data will be downloaded and the raw accelerometer files
visually screened for spurious data. Data will be proc-
essed using custom KineSoft software (KineSoft, Lough-
borough, UK). Wear time will be defined by subtracting
non-wear time from 24 h. Non-wear time will be defined
as at least 60 consecutive minutes of zero counts, with
allowance for 1–2 min of counts between 0 and 100.
McBreairty et al. BMC Nutrition  (2017) 3:23 Page 5 of 9
Time spent in different intensities (i.e. sedentary, light,
moderate and vigorous) will be calculated using pub-
lished intensity thresholds for the Actical accelerometer
[33, 34], which were used in the Canadian Health Mea-
sures Survey [35]. Total time in each intensity will be
calculated as the sum of the minutes at a given intensity
while the accelerometer is worn.
Reproductive measures
Ovarian and uterine morphology, including the ovarian
volume and the number of ovarian follicles, endometrial
thickness and endometrial pattern will be assessed at the
Royal University Hospital via transvaginal ultrasound
using a GE Voluson® 730 Pro (Zipf, Austria). The ultra-
sound examination will be timed to occur during days 1-5
of participants’ menstrual cycle, with the first day of men-
strual bleeding defined as day 1. Women who do not have
cyclical menstrual bleeding will be seen at random times.
Levels of estradiol, progesterone and an androgen index
(ratio of testosterone to sex hormone binding globulin)
will be assessed clinically at the Royal University Hospital
and the Saskatchewan Provincial Laboratory.
Dual-energy X-ray absorptiometry
Fat mass, lean mass, bone mineral content (BMC), bone
mineral density (BMD) and hip geometry will be deter-
mined using DXA (Hologic© Discovery Wi; Bedford,
MA) as previously described [35–39]. All DXA scans
will be performed and analyzed by a certified radiology
technologist. Whole body BMD and BMC, as well as
BMD of the lumbar spine (LS) (L1–L4 vertebrae) and
proximal femur regions including the femoral neck, tro-
chanter, intertrochanteric and total hip will also be de-
termined. DXA scans will also be used to determine
geometric measures at regions of the hip [40].
Leisure-time exercise questionnaire
Leisure-time exercise will be determined using a vali-
dated questionnaire [25]. The questionnaire will be ex-
plained to participants and examples of various levels of
exercise will be provided prior to completion.
4-Day food record
Participants will be given an initial 4-day food record
during baseline measures and will be provided with both
oral and written instruction for completion. Participants
will be instructed to fill out the record throughout the day
as food is consumed and will be instructed on how to pro-
vide type, quantity and preparation method. Dietary intake
data will be analyzed for energy and nutrient content
using the dietary analysis program Food Processor (ver-
sion 7, ESHA Research, Oregon). This program enables
the use of both the USDA Handbook 8 (USDA, 1999) and
the Canadian Nutrient File (CNF 1997 version). The
database includes more than 20,000 food items, including
specialty, ethnic, combination and fast foods. Other food
items also can be entered from recipes.
Glucose tolerance test
A fasted glucose tolerance test will be performed by a
physician (DRC) at the Royal University Hospital. An
intravenous catheter will be placed in the distal arm with
a saline lock attached. Blood samples will be drawn in
vacutainer tubes after discarding the saline flush from the
IV catheter and the saline flush will be restored between
blood sampling times. Following collection of a baseline
blood sample, participants will consume a Trutol 75 g
Glucose Tolerance Test Beverage (Thermo Fisher Scien-
tific, East Providence, RI) which will be followed by blood
collection every 30 min for 2 h. Blood will be collected via
6 ml EDTA or 10 ml empty collection tubes with 3 empty
and 2 EDTA tubes used at baseline, 1 empty and 2 EDTA
tubes used at 30, 60 and 90 min, and 2 empty and 2 EDTA
tubes used at 2 h. Plasma or serum samples will be ob-
tained by hospital staff by aliquoting samples into cryo-
genic vials which will be frozen at -80 °C for future
analysis of insulin and glucose. Plasma samples will also
be collected for assessment of other blood measures as de-
scribed below. At 9-weeks, clinical blood measures will be
repeated and blood collected and aliquoted as described
above using 1 empty and 2 EDTA tubes. The GTT will
correspond with the timing of the ultrasound examination
within days 1–5 of participants’ menstrual cycle.
Measures related to metabolic syndrome
Blood pressure, height, weight and waist circumference
will be determined by a research assistant at the College of
Kinesiology research facility. Weight will be measured
using a calibrated scale and height determined with a stan-
diometer. Waist circumference will be measured after re-
moving clothing from the abdomen, by locating the top of
the hip bone (iliac crest) and measuring horizontally at the
tip of the landmark. Body mass index (BMI) will be deter-
mined as mass (kg) divided by height squared (m2). Clin-
ical fasting bloodwork will be completed at the Royal
University Hospital and include fasting plasma glucose, in-
sulin, triglycerides, lipoproteins, C-reactive protein, vita-
min D and hemoglobin A1C. Fasting bloodwork collected
during the GTT or at the 9-week blood collection will be
used to determine D-lactate and methylglyoxal by a tech-
nician. Liver adiposity will be assessed via ultrasonographic
imaging using the ultrasound instrument GE Voluson® 730
Pro (Zipf, Austria) with analysis via Imagyne software to
assess for unique echotextural characteristics [41].
Data management and analysis
The present study will follow intent to treat analysis with
measurements and analysis carried out on all participants.
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All identifying information will be maintained on a secure
University of Saskatchewan password protected drive that
is shared only with principal investigators and primary re-
search assistants identified on our ethics submission. All
hard copies of identifiable information will be securely
stored in a locked filing cabinet in a locked room with re-
stricted access. A participant coding system will be used
for all data collection which will be stored separately from
identifying information.
All raw data obtained will be compiled and reviewed
for accuracy on an Excel Spreadsheet. Descriptive statis-
tics will be performed for all outcome measurements for
the presentation of group data as means + standard devi-
ation as well as to identify outliers and determine nor-
mality of the data.
The treatment effect on the dependent variables will
also be assessed by a group by time ANOVA (baseline,
9- and 16-weeks), with repeated measures on the time
factor using Statistica (Statsoft, Chicago IL). Any missing
data points at 16-weeks will be accounted for by carrying
forward the 9-week value. To verify this approach, we
will also run a sensitivity analysis including only partici-
pants who complete all 3 time points. Any differences
determined between the groups at baseline will be
used as co-variates in our analysis. Questionnaire data
(Quality of Life, Pulse Consumption, Physical Activity)
will be presented descriptively. The participants and
group categorization will be coded such that the in-
vestigators collecting and analyzing data are blinded
to which diet the participants were following.
Monitoring
Monitoring of the study will take place via yearly re-
newal of ethical approval. The ethics board has the op-
tion to review or inspect files at any time. Researchers
will have regular contact with participants at the College
of Kinesiology research gym facility where any adverse
events can be reported. All adverse events will be re-
corded and University of Saskatchewan guidelines will
be followed which require reporting of adverse events to
the ethics board if the answer was yes to all 3 of the fol-
lowing: 1). Is the nature of the problem or event unex-
pected in terms of nature, severity or frequency?; 2). Is
the nature of the problem or event related or possibly
related (to the intervention)?; and, 3). Does the nature of
the problem or event suggest that the research places
participants or others at greater risk of harm (including
physical, psychological, economic or social harm) than
was previously known or recognized, or that were not
described in the original application? Due to the short
duration of the intervention and low likelihood that ei-
ther diet will result in any adverse events of concern,
there is no data monitoring committee, stopping guide-
lines or plans for interim analysis.
Study status
This paper presents an ongoing study which includes
follow-up measures that will be carried out. Following
completion of the study, results will be presented in
peer-reviewed scientific journals with focus on measures
of infertility, metabolic syndrome, glucose response, diet,
physical activity, and quality of life.
Discussion
The present study is designed to determine whether a
pulse-based diet is equally or more effective than a
healthy control diet at reducing symptoms related to
metabolic syndrome and reproductive dysfunction in
women with PCOS. Although diet intervention studies
in women with PCOS have been carried out, this is the
first to determine the effects of a pulse-based diet in this
population. The study design outlined has several fea-
tures contributing to the novelty of this research. The
diagnoses of PCOS used in dietary intervention studies
have primarily used the Rotterdam criteria which defines
polycystic ovaries as >12 follicles [42–44]. Recently, it
has been suggested that the follicle count recommended
by the Rotterdam criteria is too low due to improve-
ments in resolving power of ultrasound images and an
accurate diagnosis of PCOS requires a threshold of 26
follicles [21, 45]. The enhanced criterion used in the
present study may allow for a more accurate representa-
tion of the PCOS population compared to similar inter-
vention studies.
The present study takes a multi-disciplinary approach by
incorporating measures from nutrition, physiology, kin-
esiology, psychology, and reproductive medicine. This
approach allows for a comprehensive integration and asso-
ciation of the various components of PCOS which may
lead to a better understanding of this multi-faceted syn-
drome. The inclusion of Kinesiology in the study produces
unique data sets such as the use of accelerometers to quan-
tify levels of activity which have been determined via self-
reported questionnaires in previous reports [46, 47], 7-day
activity records [48], physical activity recall [49] interviews
[50], and Pedometer [51]. There is a paucity of physical ac-
tivity data using accurate and objective measures in women
with PCOS [52] and the present study utilizes information
obtained using both physical activity questionnaires and
accelerometers.
The baseline data collected as necessary for the analyses
of the dietary intervention will also serve to characterize
women with PCOS. The magnitude of our study with over
100 participants providing baseline measures, will result
in an all-inclusive profile of women with PCOS which
characterizes their lifestyle (i.e., diet including pulse con-
sumption and exercise), quality of life, various health indi-
cators for risk of disease (e.g., blood parameters,
anthropometry, body composition) and infertility.
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The primary significance of the research will be to fur-
ther build on the resources used to develop evidence
based dietary recommendations for women with PCOS.
Lifestyle is currently the first line of action in treating
many symptoms of PCOS and although some diets have
been shown to improve specific symptoms of PCOS,
there is currently no consensus on an optimal diet for
women with the syndrome [53]. We expect to be able to
demonstrate whether the insulin lowering effects of a
pulse-based diet can better serve women with PCOS to
reduce their symptoms.
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